Fundraising FoxBiomarx
4 known investors
Find your way into Biomarx
Sign up to see every warm intro you have to Biomarx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biomarx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.
Founders & leadership
Investors · 4
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seedJan 2026 · 3 sources
Clarendon Fund Managers (lead), SFC Capital (lead), TechStart Ventures, University of Strathclyde
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- BIOMARX LTD
- Company number
- NI726102
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 6 Feb 2025
- Registered office
- 26 Ravenhill Park, Belfast, BT6 0DE
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 30 Nov 2025 · next due 31 Aug 2027
- Confirmation statement
- last made up to 5 Feb 2026 · next due 19 Feb 2027
Current officers · 2
- Alex Catherine Harkin — director, appointed 1 Jan 2026
- Sean Macfarlane — director, appointed 6 Feb 2025
Source: Companies House public register · retrieved 9 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Biomarx do?
- Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.
- Who founded Biomarx?
- Biomarx was founded by Sean Macfarlane.
- Who are Biomarx's investors?
- Biomarx's investors include Clarendon Fund Managers Ltd., SFC Capital, Techstart Ventures.